PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: NEW FINANCIAL YEAR UPDATE, page-130

  1. 515 Posts.
    lightbulb Created with Sketch. 43
    apologies for being dumb but even after googling it I don’t understand how nocebo could have affected our trial - because some people who got the placebo had a nocebo effect? Surely the people who got iPPS would also have had a nocebo effect too in that case?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.